|
Re: The Way Forward
|
1
|
Resverlogix Corp.
|
Oct 23, 2017 12:42PM
|
|
Re: CANTOS and CIRT
|
1
|
Resverlogix Corp.
|
Nov 14, 2017 03:20PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 04:34PM
|
|
Re: Liquidity
|
1
|
Zenith Epigenetics
|
Jan 22, 2016 05:05PM
|
|
Voting Results
|
1
|
Zenith Epigenetics
|
Nov 06, 2023 10:54AM
|
|
Re: A birthday present for DM?
|
1
|
Resverlogix Corp.
|
Aug 21, 2019 08:56AM
|
|
Re: Vote - please
|
1
|
Zenith Epigenetics
|
Oct 04, 2023 05:26PM
|
|
Re: As much as I think we're on the cusp......
|
1
|
Resverlogix Corp.
|
Sep 08, 2017 10:08AM
|
|
Re: Article
|
1
|
Resverlogix Corp.
|
Mar 15, 2022 11:27AM
|
|
Share Liquidity
|
1
|
Zenith Epigenetics
|
Dec 17, 2017 12:06PM
|
|
Re: Question for posters
|
1
|
Resverlogix Corp.
|
Dec 10, 2021 11:25AM
|
|
Re: There is hope for us
|
1
|
Zenith Epigenetics
|
Jan 09, 2018 08:26AM
|
|
Re: What's up?
|
1
|
Resverlogix Corp.
|
May 25, 2023 10:02AM
|
|
Re: Trial Status
|
1
|
Resverlogix Corp.
|
Jul 22, 2021 10:08AM
|
|
Fun post
|
1
|
Resverlogix Corp.
|
May 22, 2015 12:25PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Sep 22, 2017 03:36PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
1
|
Zenith Epigenetics
|
Apr 13, 2018 03:00PM
|
|
Re: Hopefully my email gets answered....
|
1
|
Resverlogix Corp.
|
Jun 06, 2017 10:47AM
|
|
Qatar Research overview of apabetalone
|
1
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
|
Re: zenith trials
|
1
|
Zenith Epigenetics
|
Dec 10, 2022 12:31PM
|
